New Foradil Inhaler Falls Prey To Concerns About Single-Entity LABA Products
Executive Summary
Novartis Foradil Certihaler (formoterol fumarate inhalation powder) is the first victim of a recommendation by several FDA advisory committees to withdraw the asthma indication for formoterol and salmeterol